{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T16:26:23Z","timestamp":1774715183426,"version":"3.50.1"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":890,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1111\/bjd.12189","type":"journal-article","created":{"date-parts":[[2012,12,22]],"date-time":"2012-12-22T08:14:09Z","timestamp":1356164049000},"page":"837-843","source":"Crossref","is-referenced-by-count":71,"title":["Propranolol in a case series of 174 patients with complicated infantile haemangioma: indications, safety and future directions"],"prefix":"10.1093","volume":"168","author":[{"given":"D.J.J.","family":"Hermans","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.G.","family":"Bauland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Zweegers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.M.","family":"van Beynum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.J.M.","family":"van der Vleuten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2013,3,25]]},"reference":[{"key":"10.1111\/bjd.12189-BIB1|cit1","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1097\/PRS.0b013e318208d2ac","article-title":"Untreated hemangiomas: growth pattern and residual lesions","volume":"127","author":"Bauland","year":"2011","journal-title":"Plast Reconstr Surg"},{"key":"10.1111\/bjd.12189-BIB2|cit2","doi-asserted-by":"crossref","first-page":"e423","DOI":"10.1542\/peds.2008-3458","article-title":"Propranolol for severe infantile hemangiomas: follow-up report","volume":"124","author":"Sans","year":"2009","journal-title":"Pediatrics"},{"key":"10.1111\/bjd.12189-BIB3|cit3","doi-asserted-by":"crossref","first-page":"e1239","DOI":"10.1542\/peds.2006-2962","article-title":"Oral versus high-dose pulse corticosteroids for problematic infantile hemangiomas: a randomized, controlled trial","volume":"119","author":"Pope","year":"2007","journal-title":"Pediatrics"},{"key":"10.1111\/bjd.12189-BIB4|cit4","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1056\/NEJMc0708819","article-title":"Propranolol for severe hemangiomas of infancy","volume":"358","author":"L\u00e9aut\u00e9-Labr\u00e8ze","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1111\/bjd.12189-BIB5|cit5","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ijporl.2008.10.017","article-title":"PHACES syndrome: a review","volume":"73","author":"Hartemink","year":"2009","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"10.1111\/bjd.12189-BIB6|cit6","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1001\/archdermatol.2011.203","article-title":"Propranolol vs corticosteroids for infantile hemangiomas: a multicenter retrospective analysis","volume":"147","author":"Price","year":"2011","journal-title":"Arch Dermatol"},{"key":"10.1111\/bjd.12189-BIB7|cit7","doi-asserted-by":"crossref","first-page":"e259","DOI":"10.1542\/peds.2010-0029","article-title":"A randomized controlled trial of propranolol for infantile hemangiomas","volume":"128","author":"Hogeling","year":"2011","journal-title":"Pediatrics"},{"key":"10.1111\/bjd.12189-BIB8|cit8","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1365-2133.2010.09848.x","article-title":"Propranolol for infantile haemangiomas: insights into the molecular mechanisms of action","volume":"163","author":"Storch","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.12189-BIB9|cit9","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1002\/lary.20807","article-title":"Propranolol for infantile hemangiomas: early experience at a tertiary vascular anomalies center","volume":"120","author":"Buckmiller","year":"2010","journal-title":"Laryngoscope"},{"key":"10.1111\/bjd.12189-BIB10|cit10","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/j.1365-2133.2009.09597.x","article-title":"Propranolol for complicated infantile haemangiomas: a case series of 30 infants","volume":"162","author":"Manunza","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.12189-BIB11|cit11","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.bjps.2010.06.010","article-title":"Low-dose propranolol for infantile haemangioma","volume":"64","author":"Tan","year":"2011","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"10.1111\/bjd.12189-BIB12|cit12","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1111\/j.1525-1470.2009.00975.x","article-title":"Propranolol treatment for hemangioma of infancy: risks and recommendations","volume":"26","author":"Lawley","year":"2009","journal-title":"Pediatr Dermatol"},{"key":"10.1111\/bjd.12189-BIB13|cit13","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jemermed.2003.11.015","article-title":"Are 1-2 tablets dangerous? Beta-blocker exposure in toddlers","volume":"26","author":"Love","year":"2004","journal-title":"J Emerg Med"},{"key":"10.1111\/bjd.12189-BIB14|cit14","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.jaad.2010.06.048","article-title":"Adverse effects of propranolol when used in the treatment of hemangiomas: a case series of 28 infants","volume":"65","author":"de Graaf","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.12189-BIB15|cit15","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1001\/archdermatol.2010.158","article-title":"Hypoglycemia in children taking propranolol for the treatment of infantile hemangioma","volume":"146","author":"Holland","year":"2010","journal-title":"Arch Dermatol"},{"key":"10.1111\/bjd.12189-BIB16|cit16","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1525-1470.2009.01081.x","article-title":"Severe hypoglycemia during successful treatment of diffuse hemangiomatosis with propranolol","volume":"27","author":"Bonifazi","year":"2010","journal-title":"Pediatr Dermatol"},{"key":"10.1111\/bjd.12189-BIB17|cit17","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.ijporl.2010.01.001","article-title":"Propranolol therapy for infantile haemangiomas: review of the literature","volume":"74","author":"Zimmermann","year":"2010","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"10.1111\/bjd.12189-BIB18|cit18","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.ijporl.2010.12.007","article-title":"Hemangiomas of the nasal tip: an approach to a therapeutic challenge","volume":"75","author":"Eivazi","year":"2011","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"10.1111\/bjd.12189-BIB19|cit19","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.jaad.2011.01.025","article-title":"Propranolol, a very promising treatment for ulceration in infantile hemangiomas: a study of 20 cases with matched historical controls","volume":"64","author":"Hermans","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.12189-BIB20|cit20","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1525-1470.2005.00102.x","article-title":"Infantile hemangiomas: current knowledge, future directions. Proceedings of a research workshop on infantile hemangiomas, April 7-9, 2005, Bethesda, Maryland, U.S.A","volume":"22","author":"Frieden","year":"2005","journal-title":"Pediatr Dermatol"},{"key":"10.1111\/bjd.12189-BIB21|cit21","first-page":"1","article-title":"Cutaneous hemangiomas, vascular stains and associated syndromes","volume":"17","author":"Esterly","year":"1987","journal-title":"Curr Probl Pediatr"},{"key":"10.1111\/bjd.12189-BIB22|cit22","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1111\/j.1468-3083.2010.03915.x","article-title":"Mature infantile haemangiomas role for propranolol","volume":"25","author":"O\u2019Loughlin","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/bjd.12189-BIB23|cit23","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3109\/01676830.2011.604899","article-title":"Successful treatment of orbital hemangioma with propranolol in a 5-year-old girl","volume":"31","author":"Aletaha","year":"2012","journal-title":"Orbit"},{"key":"10.1111\/bjd.12189-BIB24|cit24","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.jaad.2010.11.056","article-title":"Atenolol: a promising alternative to propranolol for the treatment of hemangiomas","volume":"65","author":"Raphael","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.12189-BIB25|cit25","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.ijporl.2010.05.013","article-title":"Management of infantile subglottic hemangioma: acebutolol or propranolol?","volume":"74","author":"Blanchet","year":"2010","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"10.1111\/bjd.12189-BIB26|cit26","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.bjps.2010.08.039","article-title":"Expression of components of the renin-angiotensin system in proliferating infantile haemangioma may account for the propranolol-induced accelerated involution","volume":"64","author":"Itinteang","year":"2011","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"10.1111\/bjd.12189-BIB27|cit27","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/j.1365-2133.2012.11016.x","article-title":"Treatment of infantile haemangioma with captopril","volume":"167","author":"Tan","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.12189-BIB28|cit28","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/j.1440-0960.2012.00901.x","article-title":"Effect of captopril on infantile haemangiomas: a retrospective case series","volume":"53","author":"Christou","year":"2012","journal-title":"Australas J Dermatol"},{"key":"10.1111\/bjd.12189-BIB29|cit29","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/IOP.0b013e31823bfffb","article-title":"A controlled study of topical 0\u00b725% timolol maleate gel for the treatment of cutaneous infantile capillary hemangiomas","volume":"28","author":"Chambers","year":"2012","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"10.1111\/bjd.12189-BIB30|cit30","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1525-1470.2011.01685.x","article-title":"Topical timolol for infantile hemangiomas: putting a note of caution in \u2018cautiously optimistic\u2019","volume":"29","author":"McMahon","year":"2012","journal-title":"Pediatr Dermatol"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjd.12189","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/bjd.12189\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T14:03:52Z","timestamp":1676383432000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/168\/4\/837\/6614314"}},"subtitle":["Propranolol in haemangioma treatment"],"short-title":[],"issued":{"date-parts":[[2013,3,25]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,4]]}},"URL":"https:\/\/doi.org\/10.1111\/bjd.12189","relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3,25]]}}}